Quantitative ROI With DCTs

Cardiology studies remain some of the most intricate and resource-intensive trials in clinical research. Even with widespread disease prevalence and extensive patient databases, identifying eligible participants is far from straightforward. Strict eligibility criteria, complex comorbidities, demanding visit schedules, and overextended clinical sites all contribute to slower-than-expected enrollment.

These challenges can stall timelines even at experienced institutions — exactly the scenario a UK sponsor encountered during a struggling cardiology study. With ten sites unable to meet recruitment targets, the sponsor turned to MRN’s Site Support services for a targeted strategy to boost patient identification and accelerate enrollment.

This preview offers a look into the complexities behind cardiology recruitment and the specialized support needed to overcome them.